Catherine Strong has more than 14 years of corporate communications and investor relations experience gained in the London and Australian markets. She has advised and supported listed and private companies through IPOs, RTOs, capital raisings and M&A across multiple sectors such as healthcare, technology, real estate, energy, support services and chemicals. Ms Strong joins Citadel-Magnus from a boutique investor and media relations firm in Sydney where she was focused on investor relations. Prior to returning to Australia, she supported a broad range of London Stock Exchange and Alternative Investment Market listed clients at London-based agency Buchanan, one of the UK’s leading and most experienced financial communication and investor relations consultancies. Her clients included Filtrona (now Essentra), Hunting and LSL Services, as well as life science clients such as Gilead Sciences, Peptech (now part of Cephalon), Genus and Immupharma. Ms Strong graduated from the Australian National University with degrees in the Science and Arts.
